Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Customized Antibiotic Duration in CAP (CAT-CAP)
NCT05903352Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2024
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in community acquired pneumonia (CAP) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Rate of cure at Day 15 after treatment initiation. Started Feb 2024; status: recruiting.
02
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT05903352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05903352.